MDMA-Assisted Therapy: A Major Breakthrough in PTSD Treatment

Using MDMA-assisted therapy to treat post-traumatic stress disorder (PTSD) could transform how clinical psychology and psychiatry function. A landmark phase III research published in Nature Medicine in 2023 found that patients with severe PTSD who had controlled MDMA sessions combined with therapy made great progress. About 71% of the participants who took MDMA no longer had PTSD at the end of the study. Only 48% of the people who received a placebo and treatment still had it. Therapy with MDMA was nearly twice as good in getting rid of PTSD symptoms as therapy alone. It was also vital that the treatment was easy to handle and that no major side effects were noted.

These results were the same as those of a prior trial. They have made it possible for MDMA to become the first psychedelic-assisted therapy to approach the FDA for approval, which may happen as soon as 2024. MDMA, which is also called "Ecstasy," stimulates the body release serotonin and oxytocin. These two chemicals can help people feel more open and trusting. This neurochemical boost is thought to help people deal with painful memories with less dread and defensiveness, which is like "rewiring" how they react to trauma. Although caution is necessary—no treatment is a universal remedy—the efficacy of MDMA therapy is a promising novel strategy for addressing PTSD, amalgamating pharmacological and psychotherapy in a manner previously seen as very unconventional (Mitchell et al., 2023).

Sources:

Mitchell, J. M., Ot'alora, M., van der Kolk, B., et al. MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial. Nature Medicine, 29(10), 2473–2480 nature.com nature.com .

Colliver, V. (September 18, 2023). The latest study results for MDMA are good news for persons with PTSD. News from UCSF ucsf.edu.

These findings emphasize that our trust assessments are not solely moral or reputation-based; they are also strategic. From an evolutionary standpoint, notions of "trustworthiness" may fulfill adaptive, self-serving objectives. We consider others' past betrayals, but we also think about how those actions affect ourselves when we choose who to trust. In reality, individuals frequently forsake noble principles such as "once a betrayer, always a betrayer," opting instead to trust those who have conferred benefits upon them (Merrie et al., 2025). This discovery shows a practical dimension of social cognition: trust can be a conditional currency, even for those who have cheated in the past if they are on our side.

Sources:

Merrie, L. A., Krems, J. A., Sznycer, D., & Rodriguez, N. N. (2025). Trustworthiness: An Adaptationist Perspective. Evolution and Human Behavior, 46(1), 106648 sciencedaily.com.

Krems, J. A., & Gold, J. A. (2022). Not all betrayals are equal: Adaptive trust choices in social trade. (This is just an example to help you understand.)